Delivery Order SPE2DB22D2211-SPE2DB25FSFCN
- Not listed
- The Defense Logistics Agency awarded a $15,543.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 tablets of Clobazam 10 mg, with an ultimate completion date of August 26, 2025. This non-set-aside contract was competitively awarded and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $3,750.23 to AmerisourceBergen Drug Corp for the supply of Clobazam 10 mg tablets (100 count) on August 6, 2025, with completion scheduled for August 7, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and...
- The Defense Logistics Agency awarded a delivery order valued at $2,637.91 to AmerisourceBergen Drug Corp for the supply of Clobazam 10 mg tablets (100 count) under a firm fixed-price contract type. The delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 3, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $8,907.91 to AmerisourceBergen Drug Corp for the supply of Clobazam 10 mg tablets in quantities of 100 units. This firm fixed-price contract, awarded on August 6, 2025, with an ultimate completion date of August 7, 2025, represents a non-set-aside competitive award. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company serves as a major pharmaceutical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $3,180.96 delivery order for 100 tablets of Clobazam 10 mg, with an ultimate completion date of August 1, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving critical federal medical procurement needs, particularly for military and veteran healthcare systems. The award...
- The Defense Logistics Agency awarded a delivery order valued at $4,667.79 to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Clobazam 10 mg tablets in quantities of 100. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of July 23, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate...
- The Defense Logistics Agency awarded a $3,196.76 delivery order to AmerisourceBergen Drug Corp for Clobazam 10 mg tablets (100 count) with an ultimate completion date of August 20, 2025. This non-competitive delivery order represents a firm fixed price purchase executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The vendor, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency awarded a delivery order valued at $2,062.99 to AmerisourceBergen Drug Corp for 100 tablets of Clobazam 10 mg, with a completion date of March 6, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $1,612.69 to AmerisourceBergen Drug Corp for 100 tablets of Clobazam 10 mg, with a completion deadline of August 11, 2025. This non-set-aside award was made under firm fixed pricing and represents a competitive delivery order issued against AmerisourceBergen's existing indefinite delivery contract (IDC) with DLA Troop Support Medical. The pharmaceutical product will be performed at AmerisourceBergen's corporate facility in...
- The Defense Logistics Agency awarded a $1,555.93 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Clobazam 10 mg tablets (100 count). This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical product will be delivered to the company's corporate office...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSFCNDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,893.33 to AmerisourceBergen Drug Corp for the supply of Clobazam 10 mg tablets (100-count packages) with an ultimate completion date of September 17, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating this was a competitively awarded procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems through its corporate office division. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and running through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The arrangement reflects DLA's strategy to maintain flexible pharmaceutical supply capabilities through established prime vendor relationships with qualified distributors capable of delivering diverse medical commodities across multiple therapeutic domains to support Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 9/16/25 |